SPONSOR
Cancer Hospital of Guangxi Medical University
Total Trials
1
Recruiting
1
Phases
N/A
Cancer Hospital of Guangxi Medical University is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Nasopharyngeal Carcinoma, Sintilimab.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Cancer Hospital of Guangxi Medical University
How many clinical trials has Cancer Hospital of Guangxi Medical University sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Cancer Hospital of Guangxi Medical University, of which 1 are actively recruiting participants. These trials cover conditions including Nasopharyngeal Carcinoma, Sintilimab. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Cancer Hospital of Guangxi Medical University research focus on?
Cancer Hospital of Guangxi Medical University clinical trials span Nasopharyngeal Carcinoma, Sintilimab. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Cancer Hospital of Guangxi Medical University clinical trial?
To participate in a Cancer Hospital of Guangxi Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Cancer Hospital of Guangxi Medical University trials with current recruitment status updated daily.
Clinical Trials by Cancer Hospital of Guangxi Medical University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology